Featured News

Halloween is just around the corner, and this year the Celiac Disease Foundation is proud to partner again with our friends at Food Allergy Research & Education (FARE) to promote the Teal Pumpkin Project, which aims to make this holiday safer for everyone affected by celiac disease, food allergies, intolerances, and other conditions.

Newly released data from Chugai Pharmaceuticals shows their drug candidate DONQ52 potently blocks gluten-specific t-cells and is ready for continued development. So, what does this mean for the celiac disease community?

On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.

The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announces its new relationship with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to provide resources for celiac disease patients and all consumers concerned about potential gluten in the company’s medications. 

The Celiac Disease Foundation and Celiac Cruise are pleased to announce an innovative partnership to offer safe and delicious gluten-free travel experiences, provide educational opportunities, and foster philanthropy within the celiac disease community.

The Celiac Disease Foundation is proud to continue our partnership with the Boston Children's Hospital in presenting "Celiac Smarts," a live-streamed symposium for the health care and celiac patient communities. Recording available now.

We know traveling safely is a priority for our celiac disease community. To promote gluten-free vacation options, the Celiac Disease Foundation is pleased to continue our long-standing partnership with Celiac…

The Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled “Celiac Disease: On the Horizon”. Recording available now.

As we look toward the summer months, the team here at the Celiac Disease Foundation is actively working on a number of new projects that are vital to elevating our mission to promote diagnosis, treatments, and a cure for celiac disease.

DDW 2023 showcased some of the latest research and innovations in celiac disease. These included promising early results from four investigational medications currently being tested for the treatment of celiac disease, as well as CDF research conducted in partnership with Takeda and Adelphi Real World.